Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Cash from Investing Activities (2017 - 2026)

Arcus Biosciences has reported Cash from Investing Activities over the past 9 years, most recently at -$182.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 456.86% year-over-year to -$182.0 million; the TTM value through Dec 2025 reached $66.0 million, up 178.57%, while the annual FY2025 figure was $66.0 million, 178.57% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$182.0 million at Arcus Biosciences, down from $79.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $137.0 million in Q2 2025 and troughed at -$268.0 million in Q1 2022.
  • A 5-year average of -$12.0 million and a median of $24.5 million in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: soared 13710.29% in 2021 and later tumbled 7259.51% in 2022.
  • Year by year, Cash from Investing Activities stood at $18.8 million in 2021, then skyrocketed by 150.24% to $47.0 million in 2022, then plummeted by 40.43% to $28.0 million in 2023, then soared by 82.14% to $51.0 million in 2024, then crashed by 456.86% to -$182.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RCUS at -$182.0 million in Q4 2025, $79.0 million in Q3 2025, and $137.0 million in Q2 2025.